Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Zic JA et al. – No studies have adequately compared the different systemic agents in patients with advanced CTCL so the clinician is left to act in the best interest of the patient with what evidence is available. When using the systemic agents, a "start low and go slow" strategy may offer patients several advantages. Dermatologists are uniquely trained to diagnose and to manage all but the most advanced stage patients with CTCL.

Related Articles

Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
British Journal of Haematology, 11/04/09    Relevance Score: 90%

Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
Cancer Science, 10/26/09    Relevance Score: 89%

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma
Journal of Clinical Oncology, 10/20/09    Relevance Score: 89%

Primary cutaneous marginal zone lymphoma
Critical Reviews in Oncology/Hematology, 10/15/09    Relevance Score: 89%

A Phase II Study of SGN-30 in Cutaneous Anaplastic Large Cell Lymphoma and Related Lymphoproliferative Disorders
Clinical Cancer Research, 10/01/09    Relevance Score: 89%

Today in Dermatologic Oncology...keeping you current

GLI1 genotypes do not predict basal cell carcinoma risk: a case control study
Molecular Cancer, 12/08/09

Multimodality management for 145 cases of Merkel cell carcinoma
Medical Oncology, 12/08/09

Creation and test of a questionnaire for self-assessment of melanoma risk factors
European Journal of Cancer Prevention, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address